Article | May 6, 2024

Improving Paediatric R&D Success: Integrating The Younger Patient And Caregiver's Perspective Into Trial Design

Source: IQVIA Research & Development Solutions

By Michael Armstrong, MD, Ph.D., senior medical director of Oncology at IQVIA Biotech; Charlie Fix, global director of Scientific Harmonization at Q2 Solutions; and Eric Neeley, Ph.D., PMP, senior director of Research Nursing & Phlebotomy Solutions at IQVIA

Cell Therapy Trial Targets Type 1 Diabetes In Children

When embarking on pediatric trials, sponsors must meticulously craft a comprehensive strategy early in the design phase, considering the myriad nuances inherent in such endeavors. IQVIA's Eric Neeley, IQVIA Biotech's Michael Armstrong, and Q2 Solutions' Charlie Fix offer invaluable insights into key considerations for enhancing pediatric clinical trials.

Delving into topics ranging from facilitating at-home trial participation to ensuring safe blood collection and fostering collaborative cancer care, these experts underscore the importance of integrating pediatric patient and caregiver perspectives into the trial design process to optimize outcomes and uphold ethical standards.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader